BioStem Technologies Reports Record Breaking Second Quarter Sales
August 25, 2021 11:15 ET
|
BioStem Technologies, Inc.
Company on Pace to Exceed 2020 Revenues in 2021 Pompano Beach, Fl., Aug. 25, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life...
BioStem Technologies, Inc., Announces the Engagement of Biologics Consulting To Support FDA Strategies and Submissions.
July 27, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., July 27, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies, Inc. Awarded Q Code for VENDAJE® Product Line From CMS.
July 23, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., July 23, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies Announces Filing of 2021 First Quarter Financial Reports
May 24, 2021 11:34 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., May 24, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue...
BioStem Technologies, Inc., Announces the Addition of Three Key Scientific Advisory Board Members
April 20, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., April 20, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies, Inc. Announces Launch of National Sales Force Expansion
April 15, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., April 15, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies, Inc. Reports Financial Results for Fourth Quarter and Fiscal Year 2020
April 05, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., April 05, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading pre-clinical-stage biotechnology company focused on...
BioStem Technologies, Inc. Receives TRIP (TRG Rapid Inquiry Program) Response for VENDAJE™
March 25, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., March 25, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies Engages D. Brooks & Associates for 2020 and 2019 Audit
March 15, 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., March 15, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading pre-clinical-stage biotechnology company focused on...
BioStem Technologies, Announces Filing of 2020 Quarterly Reports
December 24, 2020 14:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl, Dec. 24, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue...